Side-by-side comparison of AI visibility scores, market position, and capabilities
Paris YC W23 hydrogen autonomous airships for pipeline/power line inspection with 220-mile range; $3.94M Ring Capital Series A Apr 2024 with Tesla co-founder backing competing with Percepto for zero-emission critical infrastructure aerial monitoring.
HyLight is a Paris, France-based hydrogen-powered autonomous airship company — backed by Y Combinator (W23) with $3.94 million in Series A funding in April 2024 led by Ring Capital with Y Combinator, Kima Ventures, Collaborative Fund, Marc Tarpenning (Tesla co-founder), and Abhishek Tripathi — developing autonomous airships powered by hydrogen propulsion for long-range critical infrastructure inspection, targeting methane leak detection across oil and gas pipelines, power line defect inspection for electrical utilities, and railway and border monitoring applications. Founded in 2021, HyLight's airships achieve 10-hour endurance, 220-mile range, and 22 mph operational speed — enabling the continuous, wide-area monitoring that helicopters cannot provide economically and ground inspection cannot achieve at scale.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.